These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 35742035)

  • 21. The Effect of Bisphosphonates on Managing Osteoporosis After Spinal Cord Injury: A Meta-Analysis.
    Xinghua J; Junjie W; Yao G; Peng S; Jianzhong H
    Curr Pharm Des; 2020; 26(39):5072-5078. PubMed ID: 32364066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study.
    Kuo TH; Lin WH; Chao JY; Wu AB; Tseng CC; Chang YT; Liou HH; Wang MC
    BMC Nephrol; 2019 Jul; 20(1):266. PubMed ID: 31315601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sclerostin Antibody Reverses the Severe Sublesional Bone Loss in Rats After Chronic Spinal Cord Injury.
    Zhao W; Li X; Peng Y; Qin Y; Pan J; Li J; Xu A; Ominsky MS; Cardozo C; Feng JQ; Ke HZ; Bauman WA; Qin W
    Calcif Tissue Int; 2018 Oct; 103(4):443-454. PubMed ID: 29931461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives.
    Kuo TR; Chen CH
    Biomark Res; 2017; 5():18. PubMed ID: 28529755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone turnover markers: Emerging tool in the management of osteoporosis.
    Shetty S; Kapoor N; Bondu JD; Thomas N; Paul TV
    Indian J Endocrinol Metab; 2016; 20(6):846-852. PubMed ID: 27867890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sclerostin expression in the subchondral bone of patients with knee osteoarthritis.
    Wu L; Guo H; Sun K; Zhao X; Ma T; Jin Q
    Int J Mol Med; 2016 Nov; 38(5):1395-1402. PubMed ID: 27665782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth.
    Duan P; Bonewald LF
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):23-29. PubMed ID: 27210503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism.
    Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Tripathy D; Jenkinson C; Folli F
    Diabetes Care; 2015 Aug; 38(8):1509-17. PubMed ID: 26084344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of serum myostatin and sclerostin levels in chronic spinal cord injured patients.
    Invernizzi M; Carda S; Rizzi M; Grana E; Squarzanti DF; Cisari C; Molinari C; Renò F
    Spinal Cord; 2015 Aug; 53(8):615-20. PubMed ID: 25896346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal Cord Injury and Osteoporosis: Causes, Mechanisms, and Rehabilitation Strategies.
    Tan CO; Battaglino RA; Morse LR
    Int J Phys Med Rehabil; 2013; 1():. PubMed ID: 25419534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sclerostin inhibition prevents spinal cord injury-induced cancellous bone loss.
    Beggs LA; Ye F; Ghosh P; Beck DT; Conover CF; Balaez A; Miller JR; Phillips EG; Zheng N; Williams AA; Aguirre JI; Wronski TJ; Bose PK; Borst SE; Yarrow JF
    J Bone Miner Res; 2015 Apr; 30(4):681-9. PubMed ID: 25359699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of bisphosphonate analogues and functional electrical stimulation on attenuating post-injury osteoporosis in spinal cord injury patients- a systematic review and meta-analysis.
    Chang KV; Hung CY; Chen WS; Lai MS; Chien KL; Han DS
    PLoS One; 2013; 8(11):e81124. PubMed ID: 24278386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The osteocyte: an endocrine cell ... and more.
    Dallas SL; Prideaux M; Bonewald LF
    Endocr Rev; 2013 Oct; 34(5):658-90. PubMed ID: 23612223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation between renal function and serum sclerostin in adult patients with CKD.
    Pelletier S; Dubourg L; Carlier MC; Hadj-Aissa A; Fouque D
    Clin J Am Soc Nephrol; 2013 May; 8(5):819-23. PubMed ID: 23430206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanosensation and transduction in osteocytes.
    Klein-Nulend J; Bakker AD; Bacabac RG; Vatsa A; Weinbaum S
    Bone; 2013 Jun; 54(2):182-90. PubMed ID: 23085083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies.
    Battaglino RA; Lazzari AA; Garshick E; Morse LR
    Curr Osteoporos Rep; 2012 Dec; 10(4):278-85. PubMed ID: 22983921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone mineral density in spinal cord injury: an evaluation of the distal femur.
    Gaspar AP; Lazaretti-Castro M; Brandão CM
    J Osteoporos; 2012; 2012():519754. PubMed ID: 22970408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating sclerostin is elevated in short-term and reduced in long-term SCI.
    Battaglino RA; Sudhakar S; Lazzari AA; Garshick E; Zafonte R; Morse LR
    Bone; 2012 Sep; 51(3):600-5. PubMed ID: 22575440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between sclerostin and bone density in chronic spinal cord injury.
    Morse LR; Sudhakar S; Danilack V; Tun C; Lazzari A; Gagnon DR; Garshick E; Battaglino RA
    J Bone Miner Res; 2012 Feb; 27(2):352-9. PubMed ID: 22006831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss.
    Gaudio A; Pennisi P; Bratengeier C; Torrisi V; Lindner B; Mangiafico RA; Pulvirenti I; Hawa G; Tringali G; Fiore CE
    J Clin Endocrinol Metab; 2010 May; 95(5):2248-53. PubMed ID: 20305005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.